Lost in translation: animal models and clinical trials in cancer treatment
- PMID: 24489990
- PMCID: PMC3902221
Lost in translation: animal models and clinical trials in cancer treatment
Abstract
Due to practical and ethical concerns associated with human experimentation, animal models have been essential in cancer research. However, the average rate of successful translation from animal models to clinical cancer trials is less than 8%. Animal models are limited in their ability to mimic the extremely complex process of human carcinogenesis, physiology and progression. Therefore the safety and efficacy identified in animal studies is generally not translated to human trials. Animal models can serve as an important source of in vivo information, but alternative translational approaches have emerged that may eventually replace the link between in vitro studies and clinical applications. This review summarizes the current state of animal model translation to clinical practice, and offers some explanations for the general lack of success in this process. In addition, some alternative strategies to the classic in vivo approach are discussed.
Keywords: Animal models; cancer; clinical trials; review; translational studies.
Similar articles
-
Comparing translational success rates across medical research fields - A combined analysis of literature and clinical trial data.ALTEX. 2023;40(4):584-594. doi: 10.14573/altex.2208261. Epub 2023 May 5. ALTEX. 2023. PMID: 37158378
-
Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome.Prog Brain Res. 2020;251:245-268. doi: 10.1016/bs.pbr.2019.10.001. Epub 2019 Nov 1. Prog Brain Res. 2020. PMID: 32057309 Review.
-
Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25. PMID: 26269925 Free Books & Documents. Review.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
American Society of Clinical Oncology policy statement: oversight of clinical research.J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29. J Clin Oncol. 2003. PMID: 12721281
Cited by
-
Validated Preclinical Mouse Model for Therapeutic Testing against Multidrug-Resistant Pseudomonas aeruginosa Strains.Microbiol Spectr. 2022 Oct 26;10(5):e0269322. doi: 10.1128/spectrum.02693-22. Epub 2022 Sep 12. Microbiol Spectr. 2022. PMID: 36094219 Free PMC article.
-
To FLASH or to Fractionate? That is the question.Z Med Phys. 2022 Nov;32(4):387-390. doi: 10.1016/j.zemedi.2022.10.007. Epub 2022 Oct 31. Z Med Phys. 2022. PMID: 36328860 Free PMC article. No abstract available.
-
Transgenerational inheritance of metabolic disease.Semin Cell Dev Biol. 2015 Jul;43:131-140. doi: 10.1016/j.semcdb.2015.04.007. Epub 2015 Apr 29. Semin Cell Dev Biol. 2015. PMID: 25937492 Free PMC article. Review.
-
CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State.Front Immunol. 2020 Jul 7;11:1364. doi: 10.3389/fimmu.2020.01364. eCollection 2020. Front Immunol. 2020. PMID: 32733454 Free PMC article. Review.
-
Tumor-localized interleukin-2 and interleukin-12 combine with radiation therapy to safely potentiate regression of advanced malignant melanoma in pet dogs.bioRxiv [Preprint]. 2024 Feb 14:2024.02.12.579965. doi: 10.1101/2024.02.12.579965. bioRxiv. 2024. Update in: Clin Cancer Res. 2024 Sep 13;30(18):4029-4043. doi: 10.1158/1078-0432.CCR-24-0861. PMID: 38405716 Free PMC article. Updated. Preprint.
References
-
- Junod SW. U.S. Food and Drug Administration. 2013. FDA and Clinical Drug Trials: A Short History.
-
- ICH Guidance For Industry: Health Canada. 1998. General Considerations for Clinical Trials ICH Topic E8.
-
- Ledford H. Translational research: 4 ways to fix the clinical trial. Nature. 2011;477:526–8. - PubMed
-
- Arrowsmith J. Trial watch: phase III and submission failures: 2007-2010. Nat Rev Drug Discov. 2011;10:87. - PubMed
-
- Curt GA, Chabner BA. One in five cancer clinical trials is published: a terrible symptom--what’s the diagnosis? Oncologist. 2008;13:923–4. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources